The Cooper Companies, Inc. (NYSE:COO) Shares Sold by New York State Teachers Retirement System

Posted by on Apr 13th, 2023

New York State Teachers Retirement System decreased its stake in shares of The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 0.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 62,813 shares of the medical device company’s stock after selling 286 shares during the period. New York State Teachers Retirement System owned 0.13% of Cooper Companies worth $20,770,000 at the end of the most recent reporting period.

Several other hedge funds also recently bought and sold shares of the stock. Vanguard Group Inc. increased its position in Cooper Companies by 1.0% during the third quarter. Vanguard Group Inc. now owns 5,486,539 shares of the medical device company’s stock worth $1,447,898,000 after buying an additional 56,846 shares in the last quarter. State Street Corp increased its position in Cooper Companies by 0.5% during the first quarter. State Street Corp now owns 2,177,872 shares of the medical device company’s stock worth $909,458,000 after buying an additional 10,373 shares in the last quarter. Alliancebernstein L.P. increased its position in Cooper Companies by 8.1% during the third quarter. Alliancebernstein L.P. now owns 1,577,676 shares of the medical device company’s stock worth $416,349,000 after buying an additional 118,239 shares in the last quarter. Bank of New York Mellon Corp increased its position in Cooper Companies by 20.0% during the third quarter. Bank of New York Mellon Corp now owns 1,377,607 shares of the medical device company’s stock worth $363,554,000 after buying an additional 229,133 shares in the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC increased its position in Cooper Companies by 1.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,282,958 shares of the medical device company’s stock worth $338,573,000 after buying an additional 12,893 shares in the last quarter. Hedge funds and other institutional investors own 96.78% of the company’s stock.

Analyst Upgrades and Downgrades

COO has been the subject of several recent research reports. StockNews.com assumed coverage on Cooper Companies in a research report on Thursday, March 16th. They set a “hold” rating for the company. Citigroup lifted their price objective on Cooper Companies from $372.00 to $430.00 and gave the company a “buy” rating in a research report on Monday, April 3rd. Piper Sandler lifted their price objective on Cooper Companies from $350.00 to $375.00 and gave the company an “overweight” rating in a research report on Wednesday, January 11th. Mizuho lifted their price objective on Cooper Companies from $385.00 to $390.00 in a research report on Friday, March 3rd. Finally, Robert W. Baird lifted their price objective on Cooper Companies from $371.00 to $385.00 in a research report on Friday, March 3rd. Two investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $388.80.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, Director Robert S. Weiss sold 37,510 shares of the business’s stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $337.72, for a total transaction of $12,667,877.20. Following the transaction, the director now owns 70,000 shares in the company, valued at $23,640,400. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Cooper Companies news, Director Robert S. Weiss sold 37,510 shares of the business’s stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $337.72, for a total transaction of $12,667,877.20. Following the transaction, the director now owns 70,000 shares in the company, valued at $23,640,400. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CAO Agostino Ricupati sold 1,000 shares of the business’s stock in a transaction dated Friday, March 31st. The stock was sold at an average price of $370.00, for a total value of $370,000.00. Following the transaction, the chief accounting officer now owns 863 shares in the company, valued at approximately $319,310. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 39,726 shares of company stock valued at $13,451,962. Company insiders own 2.00% of the company’s stock.

Cooper Companies Price Performance

COO stock opened at $372.88 on Thursday. The stock has a 50-day moving average price of $347.87 and a two-hundred day moving average price of $320.88. The Cooper Companies, Inc. has a 12-month low of $244.21 and a 12-month high of $421.27. The company has a current ratio of 1.72, a quick ratio of 1.00 and a debt-to-equity ratio of 0.36. The company has a market cap of $18.44 billion, a PE ratio of 49.39, a price-to-earnings-growth ratio of 2.66 and a beta of 0.91.

Cooper Companies (NYSE:COO – Get Rating) last posted its quarterly earnings results on Thursday, March 2nd. The medical device company reported $2.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.66 by $0.24. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The firm had revenue of $858.50 million during the quarter, compared to the consensus estimate of $834.90 million. During the same quarter in the previous year, the business earned $3.24 earnings per share. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. As a group, research analysts predict that The Cooper Companies, Inc. will post 12.73 EPS for the current year.

Cooper Companies Profile

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Read More

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.